FT Markets Data
Redcare Pharmacy NV

EQS-Adhoc: Redcare Pharmacy’s CardLink solution extended by gematik.

Source: EQS

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval
Redcare Pharmacy’s CardLink solution extended by gematik.

15-Jul-2025 / 11:41 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Redcare Pharmacy’s CardLink solution extended by gematik.

Sevenum, 15 July, 2025. Through its technology partner, eHealth Experts, Redcare Pharmacy N.V. today received confirmation that its CardLink solution license for the redemption of e-prescriptions in Germany has been extended by the German National Digital Health Agency (gematik) until 31 January 2027 (from previously 31 March 2026).

With this extension, Redcare Pharmacy’s access to the German e-prescription market remains secured during the transition to the new Proof of Patient Presence (PoPP) infrastructure.

 

 




Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com


End of Inside Information

15-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2169930

 
End of Announcement EQS News Service

2169930  15-Jul-2025 CET/CEST